Breast cancer drug boosts survival chances: study
(AFP


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/afp/20070105/hl_afp/healthwomencancer"><img src="http://d.yimg.com/us.yimg.com/p/afp/20070105/capt.sge.fjn09.050107015836.photo00.photo.default-437x343.jpg?x=130&y=102&sig=X.C8YsWCmQNnSnSMoJO1Sw--" align="left" height="102" width="130" alt="Researchers display their results. A new study shows the breast-cancer drug Herceptin can boost early survival chances when used after standard chemotherapy to tackle a notoriously aggressive form of early breast cancer.(AFP/Getty Images/File/Alex Wong)" border="0" /></a>AFP - The breast-cancer drug Herceptin can boost early survival chances when used after standard chemotherapy to tackle a notoriously aggressive form of early breast cancer, a new study says.</p><br clear="all"/>